Isolation, characterization, and comparative genomic analysis of vB_PlaP_SV21, new bacteriophage of Paenibacillus

Arif Bozdeveci1, Rahşan Akpınar2, Şengül Alpay Karaoğlu1

  • 1Biology Department, Faculty of Arts and Sciences, Recep Tayyip Erdogan University, Rize, Turkey.

Virus Research
|September 23, 2021
PubMed

Insights

A novel bacteriophage, Paenibacillus phage SV21, effectively lyses Paenibacillus larvae, the bacteria causing American foulbrood disease in honeybees. This phage shows potential as a sustainable alternative to antibiotics for controlling this devastating honeybee pathogen.

Area of Science:

  • Microbiology
  • Virology
  • Apiculture

Background:

  • American foulbrood (AFB) is a severe bacterial disease caused by Paenibacillus larvae, leading to significant honeybee colony losses worldwide.
  • Bacteriophage therapy presents a promising, resistance-proof alternative for controlling bacterial infections in honeybees.

Purpose of the Study:

  • To isolate, characterize, and sequence a novel bacteriophage targeting Paenibacillus larvae.
  • To evaluate the potential of this bacteriophage as a biocontrol agent against AFB.

Main Methods:

  • Isolation of Paenibacillus phage SV21 from infected honeybee larvae.
  • Whole-genome sequencing, transmission electron microscopy, and comparative genomics.
  • Analysis of host range, lytic activity, burst size, and phylogenetic relationships.

Main Results:

  • Paenibacillus phage SV21 (vB_PlaP_SV21) was identified as a Podovirus with a linear dsDNA genome of 44,949 bp.
  • The phage demonstrated specific lytic activity against Paenibacillus larvae.
  • Phylogenetic analysis suggested a new cluster classification for vB_PlaP_SV21 and another singleton phage.

Conclusions:

  • Paenibacillus phage SV21 is a viable candidate for bacteriophage therapy against American foulbrood.
  • Further research into phage-host interactions and field applications is warranted for effective AFB control.